We are pleased to share this information from Citizens for Alternatives to Animal Research and Experimentation (CAARE) as well as a “read more” button that links to more detailed information from Medical Device Network. As CAARE notes below, it fits well with the recent dropping of the requirement that new drugs be tested on animals in the U.S. We would like to see Canada follow this example and drop the requirement in Canada too. Canada has recently banned the testing of cosmetics on animals and this would be a next step forward. For information about the drug testing on animals issue in Canada along with a link to the ADAV petition asking that it be stopped, click here. As well, you can see a complete list of current petitions on this site by clicking here.
AI-driven digital engineering company, Quantiphi, has introduced its Digital Animal Replacement Technology (DART) to provide a humane, accurate alternative to animal testing for drug discovery, manufacturing, and pre-clinical trials.
Artificial-intelligence company Quantiphi recently launched the Digital Animal Replacement Technology (DART) which combines human stem cells, a digital workstation, and artificial intelligence to accurately predict drug safety without the ethical and scientific problems of animal studies.
Global Leader in Healthcare and Life Science at Quantiphi, Bruno Nardone, says of its advantages over animal testing: “It enables early-stage decision-making, reduces cost, improves time-to-market, and it offers advantages like accelerated testing, customization based on genetic profiles, and relevance to human physiology.”
Now that Congress has passed the FDA Modernization Act, biotechnology and pharmaceutical companies have a greater motivation and opportunity to advance non-animal drug testing methods.
From email communication sent by Citizens for Alternatives to Animal Research and Experimentation (CAARE) sent July 20, 2023.